Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

A team of researchers from the University of Oxford and the University of Nottingham have developed a new tool, called ‘CanPredict’, able to identify the people most at risk of developing lung cancer over the next 10 years, and put them forward for screening tests earlier, saving time, money and, most importantly, lives.

A stethoscope and stack of doctor's notes

Writing in the journal Lancet Respiratory Medicine, the researchers developed and tested the tool using the anonymised health records of over 19 million adults from across the UK.

Lung cancer is the second most common cancer in incidence and the leading cause of cancer deaths worldwide. However, lung cancer screening – ‘catching it early’ – has been shown to improve survival rates. Because of this, in September 2022 the UK National Screening Committee recommended using targeted lung cancer screening. However, the committee did not recommend which tools would best be used for targeting screening at people most at risk.

Professor Fergus Gleeson, co-author of the study and Professor of Radiology in the Department of Oncology at the University of Oxford, said: 'Around 48,500 people are diagnosed with lung cancer each year in the UK. In its early stages, there are usually no obvious signs or symptoms, and it can go undetected for some time. Using a technique called low-dose computerised tomography (CT) for lung cancer screening we can catch this disease and treat it earlier, and that improves people’s outcomes.

Read the full story on the University of Oxford website